Mellouk's call: access planning from the R&D stage. Broad, transparent voluntary licensing. Technology transfer. Rapid registration. Generic competition. Public pricing. And when licenses fail, TRIPS flexibilities must stay on the table.
#MakeMedicinesAffordable #AccessToMedicines